describ
develop
optimis
valid
autom
cellbas
highthroughput
screen
assay
use
exist
luminescencebas
atplit
reagent
identifi
antivir
compound
inhibit
enteroviru
replic
antivir
efficaci
determin
measur
atp
level
cell
protect
viral
cytopath
effect
cpe
antivir
compound
pleconaril
rupintrivir
cpebas
assay
condit
optimis
cell
densiti
cellswel
viral
infect
dose
ccid
plate
assay
exhibit
excel
robust
valu
coeffici
variat
signaltobackground
ratio
rang
test
three
enteroviru
isol
circul
china
assay
also
suitabl
screen
picornavirus
polioviru
coxsackieviru
echoviru
parechoviru
enterovirus
ev
genu
enteroviru
famili
picornavirida
small
positivesens
rna
virus
includ
human
enterovirus
compris
serotyp
among
common
pathogen
infect
human
worldwid
especi
children
ev
infect
asymptomat
may
lead
ill
rang
mild
sever
even
lifethreaten
hand
foot
mouth
diseas
hfmd
asept
mening
enceph
myocard
pancreat
acut
flaccid
paralysi
neonat
sepsi
recent
year
outbreak
hfmd
caus
enteroviru
coxsackieviru
occcur
china
sever
countri
southeast
asia
date
approv
specif
antivir
therapi
avail
treat
diseas
caus
ev
thu
urgent
need
identifi
safe
broadspectrum
drug
exist
pathogen
ev
select
two
wellstudi
compound
differ
viral
target
aid
assay
optimis
pleconaril
enterovir
capsid
inhibitor
inhibit
enteroviru
replic
block
viru
uncoat
releas
viral
rna
cell
pleconaril
recent
report
antienteroviru
efficaci
treatment
neonat
sepsi
rupintrivir
also
known
irrevers
inhibitor
picornavir
c
proteas
demonstr
activ
rhinovirus
sever
ev
measur
cell
viabil
viral
cytopath
effect
cpe
inhibit
assay
use
uptak
reagent
neutral
red
mtt
tetrazolium
bromid
crystal
violet
limit
colorimetr
assay
includ
low
throughput
requir
wash
step
low
dynam
rang
low
signaltonois
ratio
cell
debri
remain
infect
cell
adher
micropl
result
high
background
low
signaltonois
overcom
disadvantag
implement
altern
assay
format
use
adenosin
triphosph
atp
luminesc
readout
previous
develop
valid
panel
positivestrand
rna
virus
atplit
luminesc
assay
use
measur
intracellular
atp
function
cell
number
andor
viabil
advantag
type
assay
homogen
natur
abil
use
adher
nonadher
cell
line
amen
autom
highthroughput
screen
ht
experi
sought
confirm
wwwnaturecomscientificreport
wwwnaturecomscientificreport
studi
describ
optimis
valid
implement
autom
cellbas
homogen
luminesc
assay
profil
antivir
activ
picornaviru
inhibitor
sever
differ
ev
serotyp
clinic
isol
relat
picornavirus
design
autom
ht
assay
platform
implement
autom
platform
fig
took
advantag
homogen
assay
format
atpluminesc
readout
smallfootprint
liquid
handler
reagent
dispens
allow
use
exist
biosafeti
cabinet
minim
chang
current
laboratori
space
need
userfriendli
softwar
customwritten
script
help
end
user
steep
learn
curv
signific
compon
platform
use
solo
singlechannel
robot
workstat
bravo
liquid
handl
platform
allow
miniaturis
assay
format
reduc
reagent
cost
facilit
ht
small
volum
transfer
serial
dilut
perform
greater
accuraci
precis
manual
transfer
without
concern
user
error
data
shown
assay
optimis
explor
optimis
autom
assay
fig
accept
accuraci
precis
sensit
would
amen
highthroughput
set
accuraci
express
close
agreement
valu
accept
either
convent
true
valu
accept
refer
valu
actual
measur
valu
typic
measur
percent
coeffici
variat
cv
accuraci
determin
replic
analysi
sampl
contain
known
concentr
rupintrivir
food
drug
administr
guidelin
recommend
cv
within
concentr
http
precis
describ
close
scatter
individu
measur
analyt
obtain
replic
sampl
homogen
sampl
typic
measur
cv
cv
within
wwwnaturecomscientificreport
wwwnaturecomscientificreport
concentr
except
lower
limit
quantit
exceed
cv
http
www
sensit
defin
lowest
concentr
measur
accept
limit
accuraci
precis
http
optimis
cell
densiti
cell
seed
densiti
plate
optimis
prevent
possibl
cell
overgrowth
may
affect
assay
sensit
establish
consist
strong
luminesc
signal
rd
human
rhabdomyosarcoma
cell
seed
micropl
differ
densiti
fig
cell
allow
grow
hour
postseed
cell
viabil
evalu
ad
atplit
reagent
read
luminesc
signal
cell
densiti
rd
cellswel
chosen
assay
densiti
gave
consist
strong
luminesc
signal
good
signaltobackground
ratio
sb
ratio
low
variabl
fig
optim
densiti
vero
african
green
monkey
kidney
cell
hela
human
cervic
adenocarcinoma
cell
determin
similar
manner
use
optim
seed
densiti
optimis
viru
titr
viru
stock
titrat
determin
dilut
gave
optim
sensit
assay
viru
titr
determin
endpoint
dilut
method
use
halflog
dilut
micropl
panel
enteroviru
parechoviru
strain
establish
cell
select
incub
time
base
previou
experi
twelvepoint
halflog
serial
dilut
viru
fig
made
determin
start
dilut
use
autom
assay
ensur
full
dynam
rang
cpe
start
viru
dilut
select
base
initi
linear
portion
curv
viru
induc
cpe
least
cell
viral
dilut
ccid
use
valid
autom
assay
use
ht
evalu
whether
autom
assay
suitabl
use
highthroughput
set
liquid
handl
instrument
configur
assay
robust
determin
use
coeffici
take
account
assay
signal
dynam
rang
data
variabl
assay
consid
robust
ht
assay
develop
defin
optim
assay
paramet
includ
cell
densiti
linear
rang
detect
sd
dmso
sd
compound
mean
dmso
mean
compound
cv
sd
signal
averag
signal
sb
foldincreas
signal
cell
control
background
viru
control
lower
cv
higher
sb
valu
contribut
increas
assay
robust
assay
demonstr
robust
high
degre
reproduc
low
deviat
includ
reproduc
cv
sb
ratio
rang
fig
use
differ
isol
tabl
addit
virus
test
also
met
criteria
robust
similar
result
obtain
data
shown
explor
abil
two
document
antivir
compound
pleconaril
rupintrivir
inhibit
ev
isol
clinic
sampl
tabl
neither
compound
exhibit
cytotox
autom
luminesc
atpreadout
assay
assay
use
crystal
violet
readout
fig
although
small
subset
ev
test
trend
observ
pleconaril
potent
effect
concentr
ec
valu
pv
sabin
strain
respect
compar
rupintrivir
respect
compound
significantli
higher
antivir
activ
clinic
isol
coxsackieviru
b
strain
coxsackieviru
strain
compar
respect
neither
compound
exhibit
antivir
activ
two
type
parechoviru
test
pronounc
differ
observ
compar
activ
strain
fermon
pleconaril
display
antivir
activ
wherea
rupintrivir
exhibit
low
nanomolar
antivir
activ
may
due
target
differ
viral
protein
test
pleconaril
rupintrivir
four
strain
interestingli
pleconaril
antivir
activ
strain
fig
rupintrivir
exhibit
antivir
activ
three
strain
circul
mainland
china
respect
wwwnaturecomscientificreport
wwwnaturecomscientificreport
convent
cellbas
antivir
drug
screen
assay
develop
base
cell
viabil
assay
atpas
kinas
activ
cytotox
introduct
cpebas
assay
use
atpluminesc
readout
antivir
activ
recent
report
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
yellow
fever
viru
coxsackieviru
approach
measur
atp
level
live
cell
protect
virusinduc
cpe
presenc
antivir
compound
use
atpspecif
luminesc
reagent
advantag
assay
atpluminesc
readout
highthroughput
homogen
mix
measur
assay
format
homogen
assay
also
advantag
nonadher
cell
line
use
desir
amen
highdens
plate
format
easili
autom
initi
work
rd
cell
observ
cell
adher
well
plastic
plate
easili
wash
autom
system
data
shown
exclud
use
rd
cell
cpe
assay
requir
adher
cell
prior
stain
distinct
disadvantag
rd
cell
optim
cell
line
mani
ev
addit
vero
cell
wash
plastic
cleanli
reagent
like
crystal
violet
stain
cell
debri
remain
adher
make
difficult
differenti
dead
cell
live
one
luminesc
atplight
wwwnaturecomscientificreport
wwwnaturecomscientificreport
cpebas
enteroviru
antivir
assay
use
atplit
reagent
atpluminesc
readout
easili
adapt
use
autom
platform
assay
also
adapt
use
cytolyt
picornavirus
use
varieti
cell
line
plate
autom
highthroughput
cellbas
assay
develop
valid
implement
profil
efficaci
antivir
compound
ev
cell
cultur
cell
viabil
measur
atp
detect
luminesc
readout
use
endpoint
antivir
compound
pleconaril
capsid
inhibitor
rupintrivir
proteas
inhibitor
evalu
model
drug
inhibit
repres
ev
human
parechovirus
htssuitabl
assay
perform
consist
accur
automationfriendli
format
assay
suitabl
use
profil
picornaviru
inhibitor
autom
luminesc
antivir
assay
multichannel
pipett
use
transfer
mm
stock
compound
stock
compound
plate
fig
row
b
flatbottom
polystyren
plate
corn
corn
ny
contain
mem
contain
fb
dilut
plate
microflo
select
dispens
biotek
winooski
vt
equip
rotat
wrist
stacker
use
add
mem
fb
medium
well
white
flatbottom
plate
perkinelm
waltham
solo
singlechannel
robot
workstat
hudson
robot
inc
springfield
nj
use
transfer
compound
dilut
quadrupl
serial
dilut
plate
fig
bravo
liquid
handl
platform
agil
technolog
inc
santa
clara
ca
execut
halflog
serial
dilut
serial
dilut
plate
transfer
dilut
compound
multipl
assay
plate
fig
cell
dilut
cellsml
mem
fb
ad
well
assay
plate
use
microflo
select
reagent
dispens
assay
plate
contain
compound
dilut
cell
incub
hour
room
temperatur
prior
ad
ccid
dilut
virus
microflo
select
reagent
dispens
use
dispens
viru
mem
gibco
fb
hyclon
thermo
fisher
scientif
waltham
assay
plate
virus
ad
entir
plate
includ
viru
control
well
contain
test
compound
assay
plate
cover
plate
lid
wrap
plastic
wrap
wwwnaturecomscientificreport
wwwnaturecomscientificreport
wet
paper
towel
place
bottom
stack
incub
co
atmospher
day
depend
viru
cell
line
final
assay
volum
appropri
incub
period
cellviru
combin
cell
lysi
buffer
follow
reconstitut
substrat
solut
ad
well
use
microflo
select
reagent
dispens
incub
minut
dark
result
luminesc
read
victor
plate
reader
second
integr
well
raw
luminesc
count
export
excel
softwar
microsoft
redmond
wa
custom
spreadsheet
calcul
percent
inhibit
cpe
well
definit
percent
inhibit
cpe
calcul
colorimetr
antivir
assay
vitro
cpe
assay
signaltonois
ratio
use
calcul
ec
express
given
viru
isol
compound
viru
combin
cell
cell
well
plate
start
compound
ensur
endpoint
compound
viru
titrat
reach
sevenpoint
titrat
curv
perform
log
step
duplic
well
compoundviru
concentr
three
replic
test
run
viru
unless
otherwis
state
appropri
incub
cell
stain
crystal
violet
crystal
violet
ethanol
deioniz
water
wash
three
time
deioniz
water
plate
airdri
viral
cpe
measur
determin
absorb
nm
wwwnaturecomscientificreport
wwwnaturecomscientificreport
viruscompound
combin
result
five
test
fell
within
one
halflog
drug
dilut
mean
ec
valu
standard
deviat
mean
report
result
within
one
drug
dilut
anoth
five
test
conduct
result
averag
viru
dilut
achiev
desir
destruct
cell
viru
passag
increas
titr
viru
inhibit
compound
concentr
test
repeat
start
lower
concentr
compound
data
use
support
find
studi
includ
within
articl
